# Physiological and Cognitive Biomarkers for Ketamine's Antidepressant Effects

> **NCT02669043** · NA · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 8 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT02669043
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-07
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Funding ended.
- **Last updated:** 2018-04-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02669043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02669043, "Physiological and Cognitive Biomarkers for Ketamine's Antidepressant Effects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02669043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*